NEWS 12 FEED & ADDITIVE MAGAZINE December 2024 Alltech publicized its 2024 Harvest Analysis, which offers early, detailed, and actionable insights about this year’s mycotoxin risks for Europe, the U.S. and Canada. Mycotoxins, which are natural substances produced by moulds and fungi, are a concern for livestock producers as they can influence feed quality and subsequent animal health and performance. Unfortunately, they are more prevalent — and more of a problem in agriculture — than ever before. According to Alltech's statement, more than 95% of crops today are contaminated with at least one mycotoxin, and usually two or more. Because these toxins are difficult to detect, they can cause significant damage to animal health before producers even realize they are present. A proactive mycotoxin management program is essential, and the first step is learning which mycotoxins pose the highest risk in specific regions, crops and species, Alltech states. Early insights reveal regional mycotoxin variability, according to the 2024 Harvest Analysis from Alltech. 2024 EUROPEAN HARVEST ANALYSIS The company’s interim report with the preliminary findings of its mycotoxin testing programme, the Alltech 2024 European Harvest Analysis, offers early, detailed and actionable insights about this year’s mycotoxin risks. The newly released interim report shows moderate to high mycotoxin risk so far in 2024, with significant regional variations. This is similar to the results seen at this time last year. According to the report, type B trichothecenes and emerging mycotoxins are most prevalent, but type B trichothecenes like deoxynivalenol are bringing the most risk in grains. “This year's weather in Europe has been extreme and unpredictable, which has been reflected in the behaviour of moulds and the production of mycotoxins. The mycotoxin risk for all animal species is medium to high, and for some mycotoxins, such as aflatoxin B1, even extremely high,” said Dr. Radka Borutova, Global Technical Support for the Technology Group at Alltech. “The application of effective mycotoxin management is the only way to break this deadlock.” Alltech shares first results from 2024 Harvest Analysis One of the leading global diversified animal health and nutrition companies, Phibro Animal Health Corporation successfully completed the acquisition of the medicated feed additive (MFA) product portfolio and certain water-soluble products from Zoetis Inc. The company states that the acquisition marks a significant step in furthering Phibro’s purpose to optimize global animal health and nutrition for better lives and a more sustainable world. “Adding this new lineup of medicated feed additives and water-soluble products across cattle, swine and poultry will complement and expand Phibro’s species and product portfolios, helping customers meet the highest standards of animal care, prevent disease, and enhance nutrition around the world,” said Jack C. Bendheim, Chairman, President and Chief Executive Officer of Phibro Animal Health Corporation. “These products fit Phibro’s core competencies and capabilities while complementing our current lineup of vaccines, nutritional specialties and mineral nutrition.” The acquisition includes a product portfolio with more than 37 product lines sold across approximately 80 countries, six manufacturing sites in the U.S., Italy and China, and a team of more than 300 employees who primarily support the manufacturing and distribution activities of the business. The agreement to acquire the business was announced on April 28, 2024. Read more>> Phibro completes acquisition of Zoetis’ MFA product portfolio
RkJQdWJsaXNoZXIy MTUxNjkxNQ==